Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDraganfly Investments Regulatory News (DRG)

  • There is currently no data for DRG

Half Yearly Report

22 Dec 2009 11:21

RNS Number : 5464E
Draganfly Investments Ltd
22 December 2009
Β 

Registration number 89889

Draganfly Investments Limited

Chairman's statement and interim results

for the period ended 31 October 2009

Interim Results for period from May 1stΒ 2009 to October 31stΒ 2009

Chairman's Statement

During the period under review net assets have fallen from 1.57 pence per share on 30thΒ April 2009 to 1.4 pence per share on October 30thΒ 2009, a decline of 11% compared with a 35% rally in the wider AIM market during the corresponding period.Β 

This underperformance primarily reflects the large proportion of remaining unquoted holdings within the portfolio, and also the performance of Sino Gas and Energy immediately prior to admission on the ASX market.Β 

Prior to flotation on the ASX in September 2009, Sino Gas and Energy announced a rights issue at AUS 25 cents per share, representing a 50% discount to the last private funding round and the prevailing holding value within the portfolio. This resulted in a significant reduction in holding value of Β£387,000. Since flotation, the shares have declined by a further 28%, despite the company providing regular market updates regarding drilling progress and further gas discoveries. Sino Gas and Energy appears on course to meet its target of proving out a reserve base of between 100 bcf and 150 bcf of gas by the end of 2010. Peer group comparisons suggest this should equate to a valuation of AUS $100m in contrast with the recent range of $24m-28m. We look forward to further company updates with confidence.Β 

Whilst the current share price performance of Sino Gas and Energy is disappointing, the listing represents a significant boost to the portfolio's liquidity and an unrealised uplift of 25% since the original investment was made.

Elsewhere within the quoted portfolio, our AIM holdings rose 42% during the period under review, reflecting a very strong performance from Sirius Exploration, the potash exploration and development company. Sirius has rapidly assembled a world-class portfolio of potash assets in North Dakota, USA, and in North East and North West Australia, and also stands at the forefront of pioneering research into Compressed Air Energy Storage (CAES) and Carbon Sequestration at a time when clean energy, and in particular Carbon Capture, take centre stage on the political agenda worldwide. Sirius Exploration shares were added to the portfolio at 2 pence per share, following which we have traded out of a proportion of the shareholding at average prices of 9 pence per share, providing a zero-cost entry point. We continue to hold the majority of the position and look forward to a very exciting 2010 for the company. We also continue to hold Rheochem, Iofina and Immedia, all of which are progressing well and continue to meet our investment criteria of either generating cash flow and profitability, or building the platform for future profits growth. We have traded Iofina and Rheochem during the period and have disposed of the position in Medicsight.

We currently have five quoted holdings:

Sino Gas and Energy

Immedia PLC

Iofina

Rheochem

Sirius Exploration

Amongst the unquoted holdings FinanceΒ IrelandΒ has not reflected any change since the last reporting period. Microsaic Systems and Atlantic Healthcare continue to develop their businesses and weΒ expect news of product commercialisation and funding in due course. Holding values for these investments remain unchanged as indeed for Continental Petroleum where we expect a resolution to the protracted process of extending the company's exploration license in early 2010.

We currently have four unquoted holdings:

FinanceΒ Ireland

Atlantic Healthcare

Continental Petroleum Limited

Microsaic Systems

We remain convinced that our portfolio carries significant re-rating potential, but company scale remains an issue that is under review. Your Board is considering various options to increase the scale of the company and looks forward to reporting on progress in the coming months.

May I take this opportunity to thank shareholders for their support and wish you all a Merry Christmas and Happy and successful New Year.

Mark Horrocks

Chairman

Β Β 

For further information please contact:

T Edward G Bayman +44 (0) 1534 787889

Dennis Edmonds +44 (0) 7796 338 372

Clive Carver

FinnCap (Nominated Adviser) +44 (0)20 7600 1658

Β Β 

Draganfly Investments Limited

UnauditedΒ Profit and loss account

for theΒ periodΒ ended 31 October 2009

Β 
Β 
Β 
Continuing Operations
Β 
Β 
Β 
Period End 31/10/09
Β 
Period End 31/10/08
Β 
Notes
Β 
Β£
Β 
Β£
Turnover
2
Β 
(62,885)
Β 
(593,180)
Administrative expenses
Β 
Β 
(124,261)
Β 
(128,049)
Operating loss
Β 
Β 
(187,146)
Β 
(721,229)
Β 
Β 
Β 
Β 
Β 
Β 
Other interest receivable and similar income
Β 
Β 
Β 
-
Β 
Β 
-
Interest payable and similar charges
Β 
Β 
Β 
-
Β 
Β 
(8,943)
Loss on ordinary activities
Β 
Β 
(187,146)
Β 
(730,172)
Β 
Β 
Β 
Β 
Β 
Β 
There are no recognised gains or losses other than those included in the profit and loss account.
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Earnings/ loss per share -basic
Β 
Β 
Β 
Β 
Β 
Basic
Β 
Β 
(0.0016)
Β 
(0.0640)

Draganfly Investments Limited

UnauditedΒ Balance sheet

as at 31 OctoberΒ 2009

Β 
Β 
31/10/09
31/10/08
Β 
Notes
Β£
Β£
Β£
Β£
Β 
Β 
Β 
Β 
Β 
Β 
Current assets
Β 
Β 
Β 
Β 
Β 
Debtors
3
7,556
Β 
20,904
Β 
Investments
Β 
1,552,742
Β 
2,118,000
Β 
Brokers cash account
Β 
48,286
Β 
-
Β 
Β 
Β 
1,608,584
Β 
2,138,904
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Creditors: amounts falling due within one year
Β 
Β 
Β 
Β 
Β 
Creditors
4
(7,326)
Β 
(12,222)
Β 
Bank overdraft
Β 
-
Β 
(57,414)
Β 
Β 
Β 
(7,326)
Β 
(69,636)
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Net assets
Β 
Β 
1,601,258
Β 
2,069,268
Β 
Β 
Β 
Β 
Β 
Β 
Capital and reserves
Β 
Β 
Β 
Β 
Β 
Called up share capital
Β 
Β 
1,142,270
Β 
1,142,270
Share premium account
Β 
Β 
1,980,303
Β 
1,980,303
Profit and loss account
Β 
Β 
(1,521,315)
Β 
(1,053,305)
Equity shareholders' funds
5
Β 
1,601,258
Β 
2,069,268
Β 
Β 
Β 
Β 
Β 
Β 

Β 

Draganfly Investments Limited

UnauditedΒ Cash flow statement

for theΒ periodΒ ended 31 OctoberΒ 2009

Notes

Period ended 31/10/09

Period ended 31/10/08

Β£

Β£

Reconciliation of operating loss to net

cash outflow from operating activities

Operating loss

(187,146)

(721,229)

Realised (gain) / loss on sale of investments

(133,282)

265,695

Unrealised loss /(profit) on revaluation of investments

196,167

339,594

(Increase) in debtors

1,814

(15,881)

(Decrease) / increase in general creditors

(6,534)

7,201

Net cash outflow from operating activities

(128,981)

(139,022)

Cash flow statement

Net cash outflow from operating activities

(128,981)

(139,022)

Returns on investments and servicing of finance

-

(8,943)

Capital expenditure and financial investment

161,373

274,599

Increase /(Decrease) in cash in theΒ period

32,392

126,634

Increase /(Decrease) in cash in theΒ period

32,392

126,634

Opening cash balanceΒ / (bank overdraft)

15,895

(184,048)

Closing cash balance /Β (bankΒ overdraft)

48,286

(57,414)

Draganfly Investments Limited

Notes to theΒ interimΒ statements

for the periodΒ ended 31 OctoberΒ 2009

1 Accounting policies

Basis of preparation The financial statements are prepared in accordance with applicableΒ UKΒ accounting standards.

Investments In accordance with FRS 26, investments are designated as at fair value through profit or loss. Quoted investments are stated at mid-market prices at the balance sheet date. Unlisted investments are stated at 'price of recent investment', reflecting the early stage nature of the investment. The following considerations are used when calculating the 'price of recent investment': (i) Where the investment being valued was itself made recently, its cost will generally provide a good indication of fair value. (ii) Where there has been a recent investment by third parties, the price of that investment will provide a basis of the valuation. Where a fair value cannot be estimated reliably, the investment is reported at cost or the carrying value at the previous reporting date, unless there is evidence that the investment has since been impaired. Taxation The company has been granted exempt company status within the meaning of Article 123A of the Income Tax (Jersey) Law 1961 (as amended). The effect of such special status is that the company is treated as a non-resident company for the purposes of Jersey tax laws and is therefore exempt from Jersey income tax on its profits arising outside Jersey and, by concession, on bank deposit interest arising in Jersey (and from any obligation to withhold Jersey income tax from any interest or dividend payments made by it). This status is renewable on an annual basis upon payment of a fee to the Comptroller of Income Tax inΒ Jersey, and it is the company's intention to maintain this status. Consequently, no provision for taxation, either current or deferred has been made in these financial statements.

2 Turnover Turnover is derived from its principal activity and includes dividends received from investments. It also includes realised and unrealised profits and losses on investments.

Β 

Draganfly Investments Limited

Notes to the interim statements

for the period ended 31 OctoberΒ 2009

3 Investments

The carrying value of investments is stated as follows:

Quoted

Β£

Unquoted

Β£

Total

Β£

Fair value of investments at 1 May 2009

357,687

1,419,293

1,776,980

Transfers

829,894

(829,894)

-

Costs of investment purchases in the period

75,000

90,394

165,394

SaleΒ proceeds of investments sold in the period

(326,767)

-

(326,767)

935,814

679,793

1,615,607

Realised losses on sale of investments included in the profit and loss account

133,282

-

133,282

Unrealised change in fair value of investments held at 30 April 2009 included in the profit and loss account

(196,167)

-

(196,167)

(62,885)

-

(62,885)

Fair value of portfolio of investments at 31Β OctoberΒ 2009

875,929

679,793

1,552,722

Millpath Limited (note 15)

-

20

20

Fair value of total investments at 31Β OctoberΒ 2009

875,929

679,813

1,552,742

4 Creditors: amounts falling due within one year

31/10/2009

Β£

31/10/2008

Β£

Bank overdraft

-

57,414

OtherΒ creditors

7,326

12,222

7,326

69,636

Β 

Notes to the interim statements

for the period ended 31 OctoberΒ 2009

5 Reconciliation of Shareholders' funds

Profit and Loss Account

Β£

Called up Share Capital

Β£

Share Premium

Account

Β£

Total

Β£

As at 1st May 2009

(1,334,169)

1,142,270

1,980,303

1,788,404

LossΒ for the period

(187,146)

-

-

(187,146)

As at 31st October 2009

(1,521,315)

1,142,270

1,980,303

1,601,258

6 Earnings per share Basic earnings per share is calculated on the basis of lossΒ for the period ofΒ Β£730,172Β andΒ 114,227,000Β shares being the weighted average number of shares in issue during the trading period.

7 Dividends No dividends have been paid or proposed.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR PUGBUPUPBGGP
Date   Source Headline
17th Apr 201511:00 amRNSStatement regarding share price movement
3rd Feb 20154:25 pmRNSNet Asset Value
30th Jan 20151:48 pmRNSInterim Results
13th Jan 20154:00 pmRNSNet Asset Value
28th Nov 201412:22 pmRNSResult of AGM
26th Nov 20143:46 pmRNSResult of GM and Consolidation
10th Nov 20147:00 amRNSSubscription and Notice of General Meeting
29th Oct 20141:31 pmRNSFinal Results
3rd Oct 20141:25 pmRNSNet Asset Value
16th Jul 20144:40 pmRNSNet Asset Value(s)
16th Jul 20144:37 pmRNSNet Asset Value(s)
30th May 201411:54 amRNSChange of Registered Office
15th May 20143:36 pmRNSNet Asset Value
11th Apr 20147:00 amRNSNet Asset Value(s)
6th Feb 20144:53 pmRNSNet Asset Value
27th Jan 20148:30 amRNSInterim Results
13th Jan 201412:49 pmRNSNet Asset Value
13th Jan 20148:50 amRNSNet Asset Value
27th Nov 201312:16 pmRNSResult of AGM
4th Nov 20131:21 pmRNSNet Asset Value(s)
31st Oct 20133:10 pmRNSHoldings in Company
31st Oct 20132:30 pmRNSNet Asset Value
30th Oct 201310:15 amRNSFinal Results
10th Sep 201310:57 amRNSNet Asset Value(s)
27th Aug 20133:08 pmRNSNet Asset Value
21st Aug 201312:45 pmRNSDirectors Dealing
21st Aug 201312:45 pmRNSHolding(s) in Company
29th Jul 20132:15 pmRNSNet Asset Value(s)
3rd Jul 20131:03 pmRNSNet Asset Value(s)
14th Jun 20137:00 amRNSDirectorate and Investment Adviser Change
10th May 201310:25 amRNSNet Asset Value
26th Apr 20137:00 amRNSNet Asset Value(s)
20th Mar 20132:27 pmRNSNet Asset Value and Investment
11th Feb 20133:33 pmRNSInvestment
4th Feb 20132:36 pmRNSNet Asset Value
30th Jan 20132:29 pmRNSHalf Yearly Report
18th Jan 201310:16 amRNSDirectorate Change
11th Jan 20138:22 amRNSNet Asset Value
21st Dec 20129:07 amRNSNet Asset Value(s)
23rd Nov 20122:22 pmRNSResult of AGM
6th Nov 20129:55 amRNSNet Asset Value(s)
5th Nov 20124:03 pmRNSNotice of AGM
25th Oct 201212:14 pmRNSFinal Results
22nd Oct 20121:57 pmRNSNet Asset Value(s)
24th Sep 20122:08 pmRNSNet Asset Value(s)
5th Sep 20124:52 pmRNSRoy Pitcher
24th Aug 201210:41 amRNSNet Asset Value(s)
13th Jul 201212:00 pmRNSNet Asset Value(s)
20th Jun 20124:02 pmRNSNet Asset Value(s)
8th May 20123:40 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.